Long-term survival in chronic lymphocytic leukemia after first primary malignancy in the United States.

被引：0
|
作者：
Bista, Amir
Uprety, Dipesh
Ghimire, Subash
Giri, Megha
Shah, Binay Kumar
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e18090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18090
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Long-term survival in chronic myelocytic leukemia after a first primary malignancy
    Brenner, Hermann
    Gondos, Adam
    Pulte, Dianne
    [J]. LEUKEMIA RESEARCH, 2009, 33 (12) : 1604 - 1608
  • [2] LONG-TERM SURVIVAL IN CHRONIC MYELOCYTIC LEUKEMIA AFTER A FIRST PRIMARY MALIGNANCY
    Pulte, D.
    Gondos, A.
    Brenner, H.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 221 - 222
  • [3] Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients
    Bloehdorn, Johannes
    Krzykalla, Julia
    Holzmann, Karlheinz
    Gerhardinger, Andreas
    Jebaraj, Billy Michael Chelliah
    Bahlo, Jasmin
    Humphrey, Kathryn
    Tausch, Eugen
    Robrecht, Sandra
    Mertens, Daniel
    Schneider, Christof
    Fischer, Kirsten
    Hallek, Michael
    Doehner, Hartmut
    Benner, Axel
    Stilgenbauer, Stephan
    [J]. HAEMATOLOGICA, 2022, 107 (03) : 615 - 624
  • [4] LONG-TERM SURVIVAL IN CHILDHOOD ACUTE LYMPHOCYTIC LEUKEMIA
    GONZALEZMARTIN, MC
    MUNOZVILLA, A
    GARCIAMIGUEL, P
    HERRERODIEZ, A
    HURTADORUANO, T
    FERNANDEZEPIFANIO, JL
    [J]. ANALES ESPANOLES DE PEDIATRIA, 1978, 11 (6-7): : 453 - 460
  • [5] Association of state Medicaid income eligibility limits and long-term survival after cancer diagnosis in the United States.
    Zhao, Jingxuan
    Han, Xuesong
    Nogueira, Leticia
    Jemal, Ahmedin
    Yabroff, Robin Robin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Long-term time trends in incidence, survival, and mortality of malignant melanoma in the United States.
    Shrivastava, Trilok
    Ghimire, Prabina
    Lingamaneni, Prasanth
    Ahuja, Kriti
    Batra, Kunnal
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] MANAGEMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA BY LONG-TERM LEUKAPHERESIS
    GOLDFINGER, D
    CAPOSTAGNO, V
    TAUB, R
    SACKS, HJ
    GATTI, R
    [J]. TRANSFUSION, 1976, 16 (05) : 532 - 532
  • [8] Long-Term Survival After Fludarabine, Cyclophosphamide, and Rituximab Treatment in Previously Untreated Chronic Lymphocytic Leukemia Patients
    Mustafa, Shokhan Mohammad
    Yassin, Ahmed Khudair
    Hassan, Kawa M.
    Sadiq, Nawsherwan
    Nadihm, Marwa N.
    Abdulrahman, Lara Lateef
    Salahaden, Shlan
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S263 - S264
  • [9] Long-term survival after fludarabine, cyclophosphamide, and rituximab treatment in previously untreated chronic lymphocytic leukemia patients
    Mustafa, Shokhan Mohammad
    Yassin, Ahmed Khudair
    Mohammed, Nawsherwan S.
    Shamoon, Rawand P.
    Karam, Marwa N.
    Mohammad, Shlan S.
    Abdulrahman, Lara Lateef
    Ahmed, Zhalla O.
    Rashid, Bryar Sabah
    Mahmood, Tavan, I
    Yousif, Rozhhat A.
    Hasan, Kawa M.
    Mohamed, Zeki A.
    Getta, Hisham A.
    Jalal, Sana D.
    Abdullah, Dana A.
    Abdulla, Basil K.
    Numan, Ghanim S.
    Karadagh, Ranan
    [J]. IRAQI JOURNAL OF HEMATOLOGY, 2021, 10 (02) : 139 - 145
  • [10] Long-Term Survival After Fludarabine, Cyclophosphamide, and Rituximab Treatment in Previously Untreated Chronic Lymphocytic Leukemia Patients
    Mustafa, Shokhan Mohammad
    Yassin, Ahmed Khudair
    Mohammed, Nawsherwan S.
    Shamoon, Rawand P.
    Karma, Marwa N.
    Mohammad, Shlan S.
    Abdulrahman, Lara Lateef
    Ahmed, Zhalla O.
    Rashid, Bryar Sabah
    Mahmood, Tavan I.
    Yousif, Rozhhat A.
    Hasan, Kawa M.
    Mohamed, Zaki A.
    Getta, Hisham A.
    Jalal, Sana D.
    Abdullah, Dana A.
    Abdulla, Basil K.
    Numan, Ghanim S.
    Karadagh, Ranan
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S260 - S261
12345